Taiwan study tracks fabry disease patients on enzyme therapy

NCT ID NCT06052800

First seen May 30, 2026 · Last updated Jun 12, 2026 · Updated 3 times

Summary

This study looks at Fabry disease patients in Taiwan who have a specific genetic change called GLA IVS4. Researchers will collect information from medical records and patient reports to understand how the disease progresses and how well treatment with agalsidase beta works. About 78 adults will take part, and the study focuses on heart health and other key measures.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FABRY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational Site Number : 1580001

    Taipei, 100, Taiwan

  • Investigational Site Number : 1580002

    Taipei, 112, Taiwan

  • Investigational Site Number : 1580003

    Taipei, 104, Taiwan

  • Investigational Site Number : 1580004

    Taichung, 407219, Taiwan

  • Investigational Site Number : 1580005

    Tainan, 704, Taiwan

Conditions

Explore the condition pages connected to this study.

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.